INCOME STATEMENT (Quarterly GAAP In millions $) |
(Jul 31 2024) I. Quarter |
(Apr 30 2024) IV. Quarter |
(Jan 31 2024) III. Quarter |
(Oct 31 2023) II. Quarter |
(Jul 31 2023) I. Quarter |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
|
33.82 |
25.40 |
37.73 |
Other Revenue |
- |
|
-0.43 |
-0.06 |
-0.63 |
Total Revenue |
40.17 |
43.50 |
33.38 |
25.34 |
37.10 |
Cost of Goods and Services Sold |
34.46 |
38.00 |
31.00 |
30.00 |
33.00 |
Gross
Profit |
5.71 |
5.50 |
2.38 |
-4.67 |
4.10 |
Selling, Administration, Marketing |
8.17 |
6.79 |
6.38 |
6.56 |
6.26 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
- |
- |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
42.63 |
44.79 |
37.38 |
36.56 |
39.26 |
Operating income/-loss
|
-2.46 |
-1.29 |
-4.00 |
-11.22 |
-2.16 |
Other Deductions / - Income |
Interest expense |
2.45 |
1.81 |
0.88 |
0.83 |
0.83 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
2.45 |
1.81 |
0.88 |
0.83 |
0.83 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
0.62 |
2.13 |
2.18 |
-0.14 |
-0.26 |
Total costs & expenses |
45.71 |
48.73 |
40.44 |
37.24 |
39.83 |
Income /-loss before income taxes |
-5.53 |
-5.23 |
-7.06 |
-11.91 |
-2.73 |
Income taxes expenses/-benefit |
- |
117.87 |
-1.05 |
-2.39 |
-0.61 |
Income after income taxes |
-5.53 |
-123.10 |
-6.01 |
-9.52 |
-2.12 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-5.53 |
-123.10 |
-6.01 |
-9.52 |
-2.12 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-5.53 |
-123.10 |
-6.01 |
-9.52 |
-2.12 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-5.53 |
-123.10 |
-6.01 |
-9.52 |
-2.12 |
EBIT |
-3.08 |
-3.42 |
-6.18 |
-11.08 |
-1.91 |
EBITD |
-0.26 |
-0.56 |
-3.37 |
-8.30 |
0.74 |
EBITDA |
0.05 |
0.03 |
-3.09 |
-8.00 |
1.08 |